Source:http://linkedlifedata.com/resource/pubmed/id/16180015
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-12-12
|
pubmed:abstractText |
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its analogues have been shown to inhibit proliferation of human cancer cells mediated by vitamin D receptor (VDR). The over-expression of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1), an enzyme involved in the metabolism of 1,25(OH)2D3 and its analogues, is associated with poor prognosis of some human cancers. In this study, we employed real-time reverse transcription PCR to examine the expression of VDR and CYP24A1 mRNA in a cohort of human breast, lung, colon and ovary tumor samples. We found that CYP24A1 mRNA was significantly up-regulated in colon, ovary and lung tumors, but down-regulated in breast tumor relative to the analogous normal tissues. As a comparison, VDR mRNA was modestly down-regulated in colon, breast and lung tumors, but highly up-regulated in ovarian tumors. Treatment of two breast cancer cell lines, SW-620 and MCF-7, and one colon cancer cell line, HT-29, by 1,25(OH)2D3 for 48 h profoundly stimulated CYP24A1 mRNA expression (EC50=0.6, 0.8 and 29.5 nM in SW-620, HT-29 and MCF-7, respectively), but did not significantly affect VDR mRNA expression. Growth as assessed by DNA synthesis was modestly arrested by 1,25(OH)2D3 after 72 h of incubation, but was not altered after a 5-day incubation period. These data suggest that the VDR signaling pathway may be compromised via the modulation of CYP24A1 and VDR in human tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcitriol,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Calcitriol,
http://linkedlifedata.com/resource/pubmed/chemical/Steroid Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/vitamin D 24-hydroxylase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
234-40
|
pubmed:dateRevised |
2008-8-16
|
pubmed:meshHeading |
pubmed-meshheading:16180015-Breast Neoplasms,
pubmed-meshheading:16180015-Calcitriol,
pubmed-meshheading:16180015-Colonic Neoplasms,
pubmed-meshheading:16180015-DNA,
pubmed-meshheading:16180015-Down-Regulation,
pubmed-meshheading:16180015-Female,
pubmed-meshheading:16180015-Gene Expression Profiling,
pubmed-meshheading:16180015-Humans,
pubmed-meshheading:16180015-Lung Neoplasms,
pubmed-meshheading:16180015-Ovarian Neoplasms,
pubmed-meshheading:16180015-RNA, Messenger,
pubmed-meshheading:16180015-Receptors, Calcitriol,
pubmed-meshheading:16180015-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16180015-Signal Transduction,
pubmed-meshheading:16180015-Steroid Hydroxylases,
pubmed-meshheading:16180015-Tumor Cells, Cultured
|
pubmed:year |
2006
|
pubmed:articleTitle |
Expression of VDR and CYP24A1 mRNA in human tumors.
|
pubmed:affiliation |
Abbott Laboratories, R4CM, AP52, 200 Abbott Park Rd., Abbott Park, IL 60064, USA.
|
pubmed:publicationType |
Journal Article
|